BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23657267)

  • 1. Resistant hypertension.
    Shariati F; Tandan N; Lavie CJ
    Curr Opin Cardiol; 2024 Jul; 39(4):266-272. PubMed ID: 38456513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    Rubin D; Lo DF; Jammula S; Carroll N; Vasudevan M
    J Hypertens; 2024 Jun; 42(6):1105-1106. PubMed ID: 38690909
    [No Abstract]   [Full Text] [Related]  

  • 3. Anxiety disorders and depression are associated with resistant hypertension.
    Duman H; Duman H; Puşuroğlu M; Yılmaz AS
    Adv Clin Exp Med; 2024 Feb; 33(2):111-118. PubMed ID: 37386855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Medicine and the Treatment of Hypertension.
    Melville S; Byrd JB
    Curr Hypertens Rep; 2019 Feb; 21(2):13. PubMed ID: 30747306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    Peeters LEJ; Koch BCP; Versmissen J
    J Hypertens; 2024 Jun; 42(6):1106-1107. PubMed ID: 38690910
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise training in the management of patients with resistant hypertension.
    Ribeiro F; Costa R; Mesquita-Bastos J
    World J Cardiol; 2015 Feb; 7(2):47-51. PubMed ID: 25717352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazilian Position Statement on Resistant Hypertension - 2020.
    Yugar-Toledo JC; Moreno Júnior H; Gus M; Rosito GBA; Scala LCN; Muxfeldt ES; Alessi A; Brandão AA; Moreira Filho O; Feitosa ADM; Passarelli Júnior O; Souza DDSM; Amodeo C; Barroso WKS; Gomes MAM; Paiva AMG; Barbosa ECD; Miranda RD; Vilela-Martin JF; Nadruz Júnior W; Rodrigues CIS; Drager LF; Bortolotto LA; Consolim-Colombo FM; Sousa MG; Borelli FAO; Kaiser SE; Salles GF; Azevedo MF; Magalhães LBNC; Póvoa RMDS; Malachias MVB; Nogueira ADR; Jardim PCBV; Jardim TSV
    Arq Bras Cardiol; 2020; 114(3):576-596. PubMed ID: 32267335
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertension.
    Faria AP; Modolo R; Moreno BV; Moreno H
    Arq Bras Cardiol; 2015 Jan; 104(1):85-9. PubMed ID: 25352458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of resistant hypertension in the United States, 2003-2008.
    Persell SD
    Hypertension; 2011 Jun; 57(6):1076-80. PubMed ID: 21502568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characteristics of resistant hypertension in the Brazilian population.
    Faria AP; Sabbatini AR; Coca A; Moreno H
    Arq Bras Cardiol; 2013 Jun; 100(6):579-82. PubMed ID: 23657267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
    Quinaglia T; Martins LC; Figueiredo VN; Santos RC; Yugar-Toledo JC; Martin JF; Demacq C; Pimenta E; Calhoun DA; Moreno H
    J Hum Hypertens; 2011 Nov; 25(11):656-64. PubMed ID: 21544090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness.
    Martins LC; Figueiredo VN; Quinaglia T; Boer-Martins L; Yugar-Toledo JC; Martin JF; Demacq C; Pimenta E; Calhoun DA; Moreno H
    J Hum Hypertens; 2011 Sep; 25(9):532-8. PubMed ID: 20927128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
    de Souza F; Muxfeldt ES; Salles GF
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
    Acelajado MC; Calhoun DA
    Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.